ALLURION TECHNOLOGIES, INC.

Surgical & Medical Instruments & Apparatus · NATICK · MA

Distress signal

Moderate confidence (50%)

Updated Oct 20, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: ALLURION TECHNOLOGIES, INC. was delisted from its exchange (Oct 13, 2026)

Every material event, newest first. History is never overwritten.

ALLURION TECHNOLOGIES, INC. was delisted from its exchange
Oct 13, 2026
Delisting effective
- SEC EDGAR — “X0203 0000876661 NEW YORK STOCK EXCHANGE LLC 0001964979 ALLURION TECHNOLOGIES, INC. 001-41767 11 HURON DR STE 200 NATICK MA MASSACHUSETTS 01760 508-647-4000 Common Stock; Warrants, each whole warrant exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share of common stock 17 CFR 240.12d2-2(b) Anthony Sozzi Analyst, Market Watch 2026-10-13”
ALLURION TECHNOLOGIES, INC. received a delisting notice from its exchange
Mar 2, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On March 2, 2026, Allurion Technologies, Inc., a Delaware corporation (the Company ) announced that it received a letter (the Delisting Notice ) from the staff of the New York Stock Exchange (the Exchange or NYSE ) indicating that the Company does not meet certain of the Exchange s continued listing standards as set forth in Section 802.01B of the NYSE Listed Company Manual that require listed companies to maintain either (i) at least $50 million in stockholders equity or (ii) at least…”

Every material source used to build this profile.

SEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0000876661 NEW YORK STOCK EXCHANGE LLC 0001964979 ALLURION TECHNOLOGIES, INC. 001-41767 11 HURON DR STE 200 NATICK MA MASSACHUSETTS 01760 508-647-4000 Common Stock; Warrants, each whole warrant exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share of common stock 17 CFR 240.12d2-2(b) Anthony Sozzi Analyst, Market Watch 2026-10-13
View source record
SEC Company Submissions (TIER 1 · UNVERIFIED)
ALLURION TECHNOLOGIES, INC. — Surgical & Medical Instruments & Apparatus (SIC 3841) — NATICK, MA
View source record
SEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On March 2, 2026, Allurion Technologies, Inc., a Delaware corporation (the Company ) announced that it received a letter (the Delisting Notice ) from the staff of the New York Stock Exchange (the Exchange or NYSE ) indicating that the Company does not meet certain of the Exchange s continued listing standards as set forth in Section 802.01B of the NYSE Listed Company Manual that require listed companies to maintain either (i) at least $50 million in stockholders equity or (ii) at least…
View source record

Every derived status, with the rule that produced it.

DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:33 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.